The trade war between the United States and China has lasted for more than one year — and a resolution is nowhere in sight.World Economyread more
The Fed is expected to cut rates Wednesday, but it is unlikely to tell markets what they want to hear on future rate cuts.Market Insiderread more
Pelosi said Trump should not have tried to address China's trade practices in a way that opened Americans up to financial pain.Politicsread more
Investors await the Fed's latest decision on monetary policy, set to be released on Wednesday stateside. The U.S. central bank is widely expected to cut rates by 25 basis...Asia Marketsread more
TransferWise posted an annual net profit of £10.3 million on revenues of £179 million.Technologyread more
Live the high life with a night's stay at Highclere Castle, the iconic stately home made famous by Downton Abbey.Spendread more
Large banking institutions face the risk of failure if interest rates in Europe continue to stay negative, warns the global chief economist of the Economist Intelligence Unit.Banksread more
The fallout from two fatal crashes of Boeing 737 Max planes has ensnared the manufacturer's most-loyal customer: Southwest Airlines. The carrier has canceled thousands of...Airlinesread more
Brent crude oil jumped the most in history in the previous session after attacks on Saudi's oil industry disrupted the kingdom's production.Marketsread more
In the survey, conducted after the third in the Democratic Party's series of debate, the former vice president draws 31% compared to 25% for the Massachusetts senator. At 14%,...2020 Electionsread more
Stocks rose slightly on Tuesday, but gains were capped as the Federal Reserve kicked off a two-day monetary policy meeting.US Marketsread more
Skechers USA: "The stock had been a red-hot momentum stock not unlike Deckers and Deckers delivered and Skechers didn't and that's why the stock came down, so it's in the penalty box until we see the next quarter."
Campbell Soup Company: "I see the stock's sneaking back and I know a lot of people feel it's going to sell itself to Kraft Heinz. I can't recommend a stock on a takeover basis if the fundamentals are deteriorating which is the case with this, so I'm going to say don't buy."
Evolus, Inc.: "Everything's a play on Botox. I had to eat crow the other day on Allergan. The stock's coming back now on Botox. I'm going to say this market's too crowded for that and I'm not going to recommend it."
Zscaler, Inc.: "It's security as a service and we like that stock very much. It's one of our faves in the group."
Dexcom, Inc.: "You know we like that. We had [CEO] Kevin Sayer on. They have the best glucose monitor. By the way, we think there's room for them and Abbott, but boy, is Dexcom on fire. I always felt that one day someone's just going to go buy the company. It would not shock me. By the way, Medtronic – [that] wouldn't be such a bad idea if you decide, 'I want to win that segment.' Just go do it."
GW Pharmaceuticals PLC: "Look, it's been red-hot. Everybody wants a legal pot play. That's one. We've been talking about Canopy. That's another. And let's not forget that Constellation Brands, STZ, which is owned by my charitable trust, they have a 20 percent stake in Canopy. Any one of those, I think, is fine."
Lockheed Martin, Inc.: "This whole group is going down because peace is apparently breaking out in the Korean peninsula. Give me a break. We like Raytheon for the charitable trust. We recognize it's going down. I think Lockheed's inexpensive too, but I see when stocks are on downtrends, you've got to give them some room. I say wait a day or two, let that stock drop another 5, 6, 7 points and then you'll be fine."
Teck Resources Limited: "The mineral stocks remain strong. At this point in the cycle, you actually are going to continue to get some strength in Teck. What a winner it's been. I think it can break out to the upside."
Disclosure: Cramer's charitable trust owns shares of Abbott Laboratories, Constellation Brands and Raytheon.